Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Revive Therapeutics Ltd (RVV.CN)

Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: Revive Therapeutics Ltd Baystreet - Thu Jan 5, 2023

Announced today that the U.S. Food & Drug Administration has granted the Company’s Type C meeting request ...

RVV.CN : 0.0250 (unch)
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Globe Newswire - Mon Jul 25, 2022

TORONTO, July 25, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty...

RVVTF : 0.0206 (-4.19%)
RVV.CN : 0.0250 (unch)
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Globe Newswire - Fri Jun 24, 2022

FDA accepts Company’s Data Access Plan to determine potential new clinical endpoints to support Emergency Use Authorization...

RVVTF : 0.0206 (-4.19%)
RVV.CN : 0.0250 (unch)
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Globe Newswire - Mon Jun 6, 2022

The Company submits Data Access Plan to the FDA to determine potential new clinical endpoints to support Emergency Use Authorization...

RVVTF : 0.0206 (-4.19%)
RVV.CN : 0.0250 (unch)
Stocks in play: Revive Therapeutics Ltd Baystreet - Thu May 26, 2022

Provides an update on the Company’s U.S. Food & Drug Administration Phase 3 clinical trial to evaluate ...

RVV.CN : 0.0250 (unch)
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Globe Newswire - Thu May 26, 2022

The Company received positive comments from the FDA to determine potential new clinical endpoints to support Emergency Use Authorization TORONTO, May 26,...

RVVTF : 0.0206 (-4.19%)
RVV.CN : 0.0250 (unch)
Stocks in play: Revive Therapeutics Ltd Baystreet - Mon May 16, 2022

Provides an update on the Company’s U.S. Food & Drug Administration Phase 3 clinical trial to evaluate ...

RVV.CN : 0.0250 (unch)
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Globe Newswire - Mon May 16, 2022

The Company submitted request to the FDA to determine potential new clinical endpoints for FDA consideration for EUA...

RVVTF : 0.0206 (-4.19%)
RVV.CN : 0.0250 (unch)
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Globe Newswire - Mon Apr 25, 2022

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty...

RVVTF : 0.0206 (-4.19%)
RVV.CN : 0.0250 (unch)
Stocks in play: Revive Therapeutics Ltd Baystreet - Mon Apr 18, 2022

Announced the publication of a scientific article evaluating the impact of medication, including Bucillamine, ...

RVV.CN : 0.0250 (unch)

Barchart Exclusives

Stock Index Futures Climb on Upbeat Big Tech Earnings, U.S. Inflation Data Looms Barchart - 46 minutes ago
June S&P 500 E-Mini futures (ESM24) are up +0.63%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.86% this morning as upbeat quarterly results from tech titans Alphabet and Microsoft boosted sentiment, while investors geared up for the release of the Fed’s preferred inflation gauge. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot